Exploring Beta Blockers in Huntington's Disease

This chapter examines the use of lipophilic and hydrophilic beta blockers in treating Huntington's disease, noting the limitations in assessing hydrophilic options. It also discusses the relationship between beta blockers and psychiatric symptoms, underscoring the need for additional research to fully understand their potential therapeutic benefits.